CCL2 and stroke disorder: A Mendelian randomization study has demonstrated that, among chemokines, a genetic predisposition to elevated circulating levels of monocyte chemotactic protein-1 (MCP-1) is associated with an increased risk of stroke, particularly large-artery atherosclerotic stroke and cardioembolic stroke [7].